- $110.51m
- $108.60m
- $1.32m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 57.17 | ||
| Price to Tang. Book | 57.56 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 83.55 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -121.38% | ||
| Return on Equity | -78.4% | ||
| Operating Margin | -194.54% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 3.45 | 1.02 | 1.86 | 1.43 | 1.32 | n/a | n/a | -3.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 1st, 2016
- Public Since
- September 17th, 2018
- No. of Shareholders
- 1,392
- No. of Employees
- 16
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 50,005,381
- Address
- 0, KUALA LUMPUR, 58100
- Web
- https://www.agapeatpgroup.com/index.php/agape-atp-corporation/introduction
- Phone
- +60 327325716
- Auditors
- Marcum Asia CPAs LLP
Upcoming Events for ATPC
Agape ATP Corp Annual Shareholders Meeting
Q2 2025 Agape ATP Corp Earnings Release
Similar to ATPC
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Alpha Tau Medical
NASDAQ Capital Market
FAQ
What is the Agape ATP share price?
As of Today at 19:06 UTC, shares in Agape ATP are trading at $2.21. This share price information is delayed by 15 minutes.
How has the Agape ATP share price performed this year?
Shares in Agape ATP last closed at $2.21 and the price had moved by -54.15% over the past 365 days. In terms of relative price strength the Agape ATP share price has underperformed the S&P500 Index by -57.68% over the past year.
What are the analyst and broker recommendations for Agape ATP?
There is no consensus recommendation for this security.
Find out moreWhat is the Agape ATP dividend yield?
Agape ATP does not currently pay a dividend.
Does Agape ATP pay a dividend?
Agape ATP does not currently pay a dividend.
When does Agape ATP next pay dividends?
Agape ATP does not currently pay a dividend.
How do I buy Agape ATP shares?
To buy shares in Agape ATP you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Agape ATP?
As of the previous close price of $2.21, shares in Agape ATP had a market capitalisation of $110.51m.
Where are Agape ATP shares listed?
Here are the trading details for Agape ATP:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ATPC
What kind of share is Agape ATP?
Based on an overall assessment of its quality, value and momentum Agape ATP is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Agape ATP share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Agape ATP share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Agape ATP. Over the past six months, its share price has outperformed the S&P500 Index by +18.84%.
As of the last closing price of $2.21, shares in Agape ATP were trading +30.83% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Agape ATP PE Ratio?
The Agape ATP PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.21.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Agape ATP?
We do not have data on Agape ATP's directors